[go: up one dir, main page]

PT2337568T - Processos e métodos para engenharia de tecidos moles - Google Patents

Processos e métodos para engenharia de tecidos moles

Info

Publication number
PT2337568T
PT2337568T PT98111602T PT09811160T PT2337568T PT 2337568 T PT2337568 T PT 2337568T PT 98111602 T PT98111602 T PT 98111602T PT 09811160 T PT09811160 T PT 09811160T PT 2337568 T PT2337568 T PT 2337568T
Authority
PT
Portugal
Prior art keywords
methods
soft tissue
tissue engineering
engineering
soft
Prior art date
Application number
PT98111602T
Other languages
English (en)
Original Assignee
Everfill Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Everfill Oy filed Critical Everfill Oy
Publication of PT2337568T publication Critical patent/PT2337568T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Dispersion Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
PT98111602T 2008-09-08 2009-09-07 Processos e métodos para engenharia de tecidos moles PT2337568T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9519808P 2008-09-08 2008-09-08
FI20085839A FI20085839A0 (fi) 2008-09-08 2008-09-08 Menetelmiä ja välineitä pehmytkudosteknologiaan

Publications (1)

Publication Number Publication Date
PT2337568T true PT2337568T (pt) 2020-05-15

Family

ID=39852230

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98111602T PT2337568T (pt) 2008-09-08 2009-09-07 Processos e métodos para engenharia de tecidos moles

Country Status (12)

Country Link
US (1) US9056084B2 (pt)
EP (1) EP2337568B1 (pt)
JP (1) JP2012502012A (pt)
CN (1) CN102143755A (pt)
BR (1) BRPI0918851B1 (pt)
DK (1) DK2337568T3 (pt)
ES (1) ES2790300T3 (pt)
FI (1) FI20085839A0 (pt)
LT (1) LT2337568T (pt)
PL (1) PL2337568T3 (pt)
PT (1) PT2337568T (pt)
WO (1) WO2010026299A1 (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009288118B2 (en) 2008-09-02 2014-12-11 Allergan, Inc. Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
CA2789368C (en) 2010-03-04 2017-10-17 Ajinomoto Co., Inc. Coffee whitener, process for producing same, and process for producing beverage
EP2542230A4 (en) * 2010-03-05 2013-08-28 Harvard College PROMOTING THE ADHESION OF SKELETAL MUSCLE STEM CELLS BY SIMULTANEOUS ADMINISTRATION OF VEGF AND IGF-1
DK2550027T4 (da) 2010-03-22 2019-05-13 Allergan Inc Tværbundne polysaccharid- og protein-polysaccharid-hydrogeler til blødvævsforøgelse
GB201007159D0 (en) * 2010-04-29 2010-06-09 Nhs Blood & Transplant Method for evaluating anglogenic potential
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8894992B2 (en) 2010-08-19 2014-11-25 Allergan, Inc. Compositions and soft tissue replacement methods
US8900571B2 (en) 2010-08-19 2014-12-02 Allergan, Inc. Compositions and soft tissue replacement methods
US8926963B2 (en) 2010-08-19 2015-01-06 Allergan, Inc. Compositions and soft tissue replacement methods
BR112013021035A2 (pt) * 2011-02-17 2016-10-11 Allergan Inc composições e métodos de reposição de tecido macio aperfeiçoados
ES2738208T3 (es) 2011-06-03 2020-01-20 Allergan Ind Sas Composiciones de relleno dérmico que incluyen antioxidantes
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9296781B2 (en) * 2011-06-28 2016-03-29 Veris Medical, Inc. System and method for collagen isolation
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
EP2802308A1 (en) * 2012-01-13 2014-11-19 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
AU2013202570A1 (en) * 2012-03-23 2013-10-10 Neopec Pty Ltd Tissue scaffold
EP2687224A1 (en) * 2012-07-19 2014-01-22 Tissue Med Biosciences Forschungs- und Entwicklungsgesellschaft mbH Medicament for wound treatment
WO2014164815A2 (en) 2013-03-12 2014-10-09 Allergan, Inc. Adipose tissue combinations, devices, and uses thereof
US20140350516A1 (en) 2013-05-23 2014-11-27 Allergan, Inc. Mechanical syringe accessory
AU2014284440B2 (en) * 2013-07-01 2018-07-19 Amit Prakash Govil Soft tissue implant
US20150037436A1 (en) 2013-07-30 2015-02-05 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US9248384B2 (en) 2013-10-02 2016-02-02 Allergan, Inc. Fat processing system
US10029048B2 (en) 2014-05-13 2018-07-24 Allergan, Inc. High force injection devices
ES2761558T3 (es) 2014-09-30 2020-05-20 Allergan Ind Sas Composiciones de hidrogel estables que incluyen aditivos
PL3256179T3 (pl) 2015-02-13 2020-05-18 Allergan Industrie, Sas Implanty do kształtowania, uwydatniania lub korygowania cech twarzy takich jak broda
EP3268063A4 (en) 2015-03-10 2018-10-31 Allergan Pharmaceuticals Holdings (Ireland) Unlimited Company Multiple needle injector
EP3297694A1 (en) 2015-05-21 2018-03-28 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
KR102232054B1 (ko) 2016-04-08 2021-03-26 알레간 인코포레이티드 흡인 및 주입 디바이스
DK3335696T3 (da) * 2016-12-15 2020-03-16 Upm Kymmene Corp Fremgangsmåde til tørring af cellefrit vævsekstrakt i en hydrogel omfattende nanofibrillær cellulose og en tørret hydrogel omfattende nanofibrillær cellulose og cellefrit vævsekstrakt
IT201700102994A1 (it) 2017-09-14 2019-03-14 Genlife Sagl Catalizzatore rigenerativo di tessuti e relativo procedimento di realizzazione
CN110496241A (zh) * 2018-05-16 2019-11-26 上海交通大学医学院附属第九人民医院 取自脂肪组织的生物材料及其制备方法和用途
CN112675153B (zh) * 2019-10-17 2024-12-27 上海萨丽斐生物科技有限公司 无细胞脂肪组织提取物促进毛发生长、固发的用途
CA3161606A1 (en) * 2019-11-15 2021-05-20 Neoprogen, Inc. Immortalized cardiac stem cells for cardiac repair
CN113398331A (zh) * 2021-05-25 2021-09-17 郑州市和沐生物科技有限公司 无细胞脂肪提取物及其制备方法、分析方法
CN115044541B (zh) * 2022-05-24 2023-08-15 南京农业大学 高分化效率永生猪脂肪前体细胞系及其构建方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0411621A (pt) * 2003-06-18 2006-08-08 Macropore Biosurgery Inc métodos de uso de células derivados de tecido adiposo no aumento de transferência de gordura autóloga
WO2005121316A1 (en) * 2004-06-11 2005-12-22 Bernard O'brien Institute Of Microsurgery Tissue material and muscle derived matrix
AU2005282384B2 (en) * 2004-09-08 2011-09-01 Myocardial Therapeutics, Inc. Conditioned medium of autologous or allogenic progenitor cells for angiogenesis treatment
EP3205349A1 (en) * 2006-10-02 2017-08-16 Orthocell Limited A method of producing native components, such as growth factors or extracellular matrix proteins, through cell culturing of tissue samples for tissue repair
CA2715288C (en) * 2008-02-11 2018-06-05 Gedge Rossen Compositions and methods for implantation of adipose tissue and adipose tissue products

Also Published As

Publication number Publication date
EP2337568A4 (en) 2014-02-19
FI20085839A0 (fi) 2008-09-08
BRPI0918851B1 (pt) 2019-06-25
US20110151005A1 (en) 2011-06-23
BRPI0918851A2 (pt) 2015-12-08
EP2337568B1 (en) 2020-02-19
EP2337568A1 (en) 2011-06-29
JP2012502012A (ja) 2012-01-26
DK2337568T3 (da) 2020-05-11
ES2790300T3 (es) 2020-10-27
CN102143755A (zh) 2011-08-03
PL2337568T3 (pl) 2020-08-10
US9056084B2 (en) 2015-06-16
WO2010026299A1 (en) 2010-03-11
LT2337568T (lt) 2020-05-25

Similar Documents

Publication Publication Date Title
PT2337568T (pt) Processos e métodos para engenharia de tecidos moles
IL217340A0 (en) Devices and methods for tissue engineering
IL218663A0 (en) Devices and methods for tissue engineering
EP2211729A4 (en) DEVICES AND METHOD FOR FIXING TISSUE
EP2515787A4 (en) SURGICAL GUIDANCE AND METHOD THEREFOR
SG174985A1 (en) Surgical device and method
GB0803725D0 (en) Surgical apparatus and procedure
IL199797A0 (en) Methods and devices for heart tissue repair
EP2262450A4 (en) IMPLANTS AND METHODS OF USE
GB0802402D0 (en) Medical device and method
ZA201000658B (en) Surgical kits and methods
EP2429584A4 (en) TREATMENT PROCEDURE AND COMPOSITIONS
EP2280680A4 (en) METHODS AND DEVICES FOR DISSOLVING TISSUE
EP2222314A4 (en) METHOD AND MEANS FOR OBTAINING BRONCHORELAXATION
GB0903299D0 (en) Composition and methods
GB0802277D0 (en) Medical device and method
PL2442729T3 (pl) Sposób i zestaw do opatrywania tkanek
TWI370107B (en) Novel methods for making and using halosilylgermanes
IL217734A0 (en) Methods and devices for tissue ablation
GB0823333D0 (en) Apparatus and methods
EP2427129A4 (en) DEVICES AND METHODS FOR MODIFYING FABRICS
EP2512504A4 (en) COMPOSITION AND THERAPEUTIC METHOD
GB0909380D0 (en) Method and use
GB0823408D0 (en) Apparatus and methods
EP2162084A4 (en) METHOD AND DEVICE FOR TREATMENT OF TISSUE